![Aleksandar Danilovski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aleksandar Danilovski
Directeur/Membre du Conseil chez
ACTIVE BIOTECH AB
Profil
Aleksandar Danilovski is the founder of Dalisco doo, established in 2023, serving as Managing Partner.
Current jobs include Independent Director at Active Biotech AB since 2020, Director at Pharmaero ApS, and Chief Scientific Officer at Xellia Pharmaceuticals ApS since 2020.
Former jobs include Principal at PLIVA, Inc., Head-European Research & Development at Barr Laboratories, Inc., Member-Management Board at PLIVA Pharmaceuticals, Inc., Principal at The Barr Group, Inc., Member-Management Board at PLIVA Croatia Ltd. from 2011 to 2012, and Member-Scientific Selection Board at Novo Holdings A. Education includes a doctorate from the University of Cambridge and both undergraduate and doctorate degrees from the University of Zagreb.
Postes actifs de Aleksandar Danilovski
| Sociétés | Poste | Début |
|---|---|---|
| ACTIVE BIOTECH AB | Directeur/Membre du Conseil | 01/01/2020 |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Pharmaero ApS | Directeur/Membre du Conseil | - |
Anciens postes connus de Aleksandar Danilovski
| Sociétés | Poste | Fin |
|---|---|---|
PLIVA Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | Corporate Officer/Principal | - |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Corporate Officer/Principal | - |
PLIVA Croatia Ltd. | Directeur/Membre du Conseil | - |
The Barr Group, Inc.
 The Barr Group, Inc. The Barr Group, Inc. is a private company based in Nashville, TN. | Corporate Officer/Principal | - |
Formation de Aleksandar Danilovski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade Develops, produces, and sells drugs and pharmaceutical products | Retail Trade |
University of Zagreb
 University of Zagreb Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | Health Technology |
PLIVA Pharmaceuticals, Inc. | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services | Health Services |
The Barr Group, Inc.
The Barr Group, Inc. The Barr Group, Inc. is a private company based in Nashville, TN. | |
PLIVA Croatia Ltd. | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Pharmaero ApS |
